Maowia Mukhtar1, Asim Abdoun1, Abdallah E Ahmed1, Hashim Ghalib2, Steven G Reed2, Marleen Boelaert3, Joris Menten3, Musa M Khair4, Randall F Howard5. 1. Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan. 2. Infectious Disease Research Institute (IDRI), Seattle, WA, USA. 3. Institute of Tropical Medicine, Antwerp, Belgium. 4. Faculty of Medicine, University of Khartoum, Khartoum, Sudan. 5. Infectious Disease Research Institute (IDRI), Seattle, WA, USA randall.howard@idri.org.
Abstract
BACKGROUND: Rapid diagnostic tests (RDTs) for visceral leishmaniasis (VL) based on rK39 antigen showed suboptimal sensitivity in East Africa. A prospective clinical cohort study in Sudan was designed to validate a novel rK28-based RDT for Leishmania donovani VL. METHODS: Patients (n=285) suspected of VL by residency, fever for ≥2 weeks, splenomegaly with no prior reported VL, and negative for malaria were consecutively enrolled at three Sudanese sites in 2012-2013 and informed consent obtained. Two human readers, who were blinded to the clinical status and other RDT results, evaluated patient whole blood (WB) and serum on the rK28 RDT. Based on Leishmania parasite detection in lymph node or bone marrow aspirates (Giemsa-stained smears or culture in Novy-MacNeal-Nicolle medium), patients were categorized as VL cases (n=200) or VL controls (n=85). RESULTS: The rK28 RDT had high specificity using either WB (100% [85/85]) or serum (97.6% [83/85]) and exhibited greater sensitivity (WB, 92.5% [185/200]; serum, 94.5% [189/200]) than a direct agglutination test performed with the same sera (92.9% [79/85] and 83.5% [167/200] for specificity and sensitivity, respectively). Two blinded readers scored a given WB or serum sample the same on the rK28 RDT 99.6% and 100% of the time, respectively. A reader scored each individual donor's paired WB and serum rK28 RDT results the same 97.2% of the time. CONCLUSIONS: An inexpensive rK28 RDT that performs robustly with WB or serum will be valuable for diagnosing cases of VL in East Africa.
BACKGROUND: Rapid diagnostic tests (RDTs) for visceral leishmaniasis (VL) based on rK39 antigen showed suboptimal sensitivity in East Africa. A prospective clinical cohort study in Sudan was designed to validate a novel rK28-based RDT for Leishmania donovani VL. METHODS:Patients (n=285) suspected of VL by residency, fever for ≥2 weeks, splenomegaly with no prior reported VL, and negative for malaria were consecutively enrolled at three Sudanese sites in 2012-2013 and informed consent obtained. Two human readers, who were blinded to the clinical status and other RDT results, evaluated patient whole blood (WB) and serum on the rK28 RDT. Based on Leishmania parasite detection in lymph node or bone marrow aspirates (Giemsa-stained smears or culture in Novy-MacNeal-Nicolle medium), patients were categorized as VL cases (n=200) or VL controls (n=85). RESULTS: The rK28 RDT had high specificity using either WB (100% [85/85]) or serum (97.6% [83/85]) and exhibited greater sensitivity (WB, 92.5% [185/200]; serum, 94.5% [189/200]) than a direct agglutination test performed with the same sera (92.9% [79/85] and 83.5% [167/200] for specificity and sensitivity, respectively). Two blinded readers scored a given WB or serum sample the same on the rK28 RDT 99.6% and 100% of the time, respectively. A reader scored each individual donor's paired WB and serum rK28 RDT results the same 97.2% of the time. CONCLUSIONS: An inexpensive rK28 RDT that performs robustly with WB or serum will be valuable for diagnosing cases of VL in East Africa.
Authors: Maria Marta Figueiredo; Anna R R Dos Santos; Lara C Godoi; Natália S de Castro; Bruno C de Andrade; Sarah A R Sergio; Selma M B Jerônimo; Edward J de Oliveira; Ruth T Valencia-Portillo; Lucilândia M Bezerra; Hiro Goto; Maria C A Sanchez; Caroline Junqueira; Santuza M R Teixeira; Flávio G da Fonseca; Ricardo T Gazzinelli; Ana Paula Fernandes Journal: J Immunol Res Date: 2021-04-28 Impact factor: 4.818
Authors: Maowia Mukhtar; Sababil S Ali; Salah A Boshara; Audrey Albertini; Séverine Monnerat; Paul Bessell; Yasuyoshi Mori; Yutaka Kubota; Joseph M Ndung'u; Israel Cruz Journal: PLoS Negl Trop Dis Date: 2018-02-14
Authors: José Angelo Lauletta Lindoso; Carlos Henrique Valente Moreira; Mirella Alves Cunha; Igor Thiago Queiroz Journal: HIV AIDS (Auckl) Date: 2018-10-15
Authors: Temmy Sunyoto; Julien Potet; Margriet den Boer; Koert Ritmeijer; Jose A R Postigo; Raffaella Ravinetto; Fabiana Alves; Albert Picado; Marleen Boelaert Journal: BMJ Open Date: 2019-05-30 Impact factor: 2.692